Drug giant Pfizer plans to invest $500 million to expand its manufacturing plant in Stanford, N.C., which focuses on gene therapy development, according to EndPoints News.
The expanded facility will add additional capacities and capabilities to support Pfizer's growing gene therapy unit.
The Sanford-based plant currently manufactures therapies for hemophilia B and Duchenne muscular dystrophy, among other gene therapies.
The expanded facility will create about 300 jobs.